Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,049 Cr
up ₹5.5 Cr vs Dec 2020
- Stocks held
- 24
- down 1 vs Dec 2020
- Top 10 weight
- 62.7%
- of the portfolio in its ten largest
- Cash & debt
- 2.4%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 14
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2021 it disclosed 24 stocks worth ₹1,049 Cr, up ₹5.5 Cr from Dec 2020. Its largest positions were Cipla Limited (9.3%), Lupin Limited (8.0%), Dr. Reddy's Laboratories Limited (7.3%); the ten largest together made up 62.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 65.4% of its equity. Cash and debt stood at 2.4%. Compared with Dec 2020 the fund entered 0 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
87%
Top-10 weight is higher than 87% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
33%
Holds more cash than 33% of peers
What these mean: concentration · cash
Holdings in January 2021
Download CSVEvery line the fund disclosed, with the change against Dec 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cipla Limited | 9.29% | up 0.02 pts | ₹97.5 Cr | up ₹70 L | Added |
| Lupin Limited | 8.03% | up 1.21 pts | ₹84.2 Cr | up ₹13 Cr | Added |
| Dr. Reddy's Laboratories Limited | 7.35% | down 1.01 pts | ₹77.1 Cr | down ₹10.1 Cr | Trimmed |
| Sun Pharmaceutical Industries Limited | 7.11% | up 2.07 pts | ₹74.6 Cr | up ₹22 Cr | Added |
| IPCA Laboratories Limited | 6.97% | down 1.31 pts | ₹73.1 Cr | down ₹13.3 Cr | Trimmed |
| Procter & Gamble Health Limited | 5.78% | up 0.21 pts | ₹60.6 Cr | up ₹2.5 Cr | Added |
| Divi's Laboratories Limited | 5.40% | down 0.79 pts | ₹56.6 Cr | down ₹7.9 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 5.14% | up 0.27 pts | ₹53.9 Cr | up ₹3.1 Cr | Added |
| Max Healthcare Institute Limited | 4.13% | up 0.54 pts | ₹43.3 Cr | up ₹5.9 Cr | Added |
| Torrent Pharmaceuticals Limited | 3.53% | down 0.28 pts | ₹37 Cr | down ₹2.8 Cr | Trimmed |
| Intuitive Surgical Inc | 3.25% | down 0.32 pts | ₹34.1 Cr | down ₹3.1 Cr | Trimmed |
| Abiomed Inc | 3.25% | up 0.21 pts | ₹34 Cr | up ₹2.3 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 3.03% | down 0.49 pts | ₹31.8 Cr | down ₹5 Cr | Trimmed |
| JB Chemicals & Pharmaceuticals Limited | 3.01% | down 0.06 pts | ₹31.6 Cr | down ₹50 L | Trimmed |
| Narayana Hrudayalaya Limited | 2.80% | down 0.03 pts | ₹29.3 Cr | down ₹17 L | Trimmed |
| Dr. Lal Path Labs Limited | 2.77% | down 0.09 pts | ₹29 Cr | down ₹75 L | Trimmed |
| Abbott Laboratories | 2.72% | up 0.32 pts | ₹28.5 Cr | up ₹3.5 Cr | Added |
| Syngene International Limited | 2.51% | down 0.34 pts | ₹26.3 Cr | down ₹3.4 Cr | Trimmed |
| Alkem Laboratories Limited | 2.50% | up 0.05 pts | ₹26.2 Cr | up ₹70 L | Added |
| Cash, TREPS & receivables | 2.43% | up 0.59 pts | ₹25.4 Cr | up ₹6.3 Cr | Added |
| Indoco Remedies Limited | 2.38% | down 0.04 pts | ₹24.9 Cr | down ₹29 L | Trimmed |
| Alembic Pharmaceuticals Limited | 2.02% | down 0.18 pts | ₹21.2 Cr | down ₹1.8 Cr | Trimmed |
| Aarti Drugs Limited | 1.96% | down 0.10 pts | ₹20.5 Cr | down ₹97 L | Trimmed |
| Unichem Laboratories Limited | 1.80% | up 0.15 pts | ₹18.9 Cr | up ₹1.7 Cr | Added |
| Abbott India Limited | 0.86% | down 0.10 pts | ₹9 Cr | down ₹98 L | Trimmed |
What changed, Dec 2020 to Jan 2021
New New positions (0)
None.
Exited Exited (1)
- Ajanta Pharma Limitedwas 0.5% · ₹5.2 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹22 Cr (+2.07% pts)
- Lupin Limitedup ₹13 Cr (+1.21% pts)
- Max Healthcare Institute Limitedup ₹5.9 Cr (+0.54% pts)
- Abbott Laboratoriesup ₹3.5 Cr (+0.32% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2020, the weight rose most in Healthcare Services (+0.7 pts) and Pharmaceuticals (+0.5 pts), and fell most in Insurance (−0.5 pts) and Pharmaceuticals & Biotechnology (−0.4 pts).
- Healthcare Services20.4% → 21.1%+0.7 pts
- Pharmaceuticals6.6% → 7.1%+0.5 pts
- Insurance3.6% → 3.1%−0.5 pts
- Pharmaceuticals & Biotechnology65.8% → 65.4%−0.4 pts
- Healthcare Equipment & Supplies3.6% → 3.3%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2020 | Jul 2020 | Oct 2020 | Dec 2020 | Jan 2021 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.6% | 66.7% | 63.5% | 65.8% | 65.4% |
| Healthcare Services | 21.6% | 17.2% | 21.4% | 20.4% | 21.1% |
| Pharmaceuticals | 11.4% | 9.6% | 7.6% | 6.6% | 7.1% |
| Healthcare Equipment & Supplies | — | 3.0% | 3.8% | 3.6% | 3.3% |
| Insurance | 1.4% | 3.5% | 3.6% | 3.6% | 3.1% |
Allocation in Jan 2021change vs Dec 2020
- Pharmaceuticals & Biotechnology (13)65.4%▼ 0.4 pts
- Healthcare Services (6)21.1%▲ 0.7 pts
- Pharmaceuticals (3)7.1%▲ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2021
2.4%
▲ 0.6 pts vs Dec 2020
- Cash alone
- 2.4%
- cash and net receivables
- A year earlier
- 3.2%
- Jan 2020 · now ▼ 0.8 pts
- Last 12 months
- 1.8% – 8.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.